Regencell Bioscience HoldingRGC
13F holders, Q1 2026 (March 31)31holders +14
18new positions
4sold out
$25.43avg. 13F price*
At the end of Q1 2026, 31 institutions reported holding Regencell Bioscience Holding (RGC) in their 13F filings, up 14 from Q4 2025. 18 opened new positions and 4 sold out. The largest holders were Geode Capital Management, LLC ($10.6M), Marex Group Ltd ($804K) and Gsa Capital Partners LLP ($803K).
- Company
- Regencell Bioscience Holding
- CUSIP
- G7487R100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 18 | $2.7M |
| Exits | 4 | $694K |
All 13F filers, Q4 2025 → Q1 2026: 133,870 shares bought and 35,050 shares sold, net +98,820 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| Geode Capital Management, LLC | 0.00% | Add +0.6% | 415,569 | $10.6M |
| Marex Group Ltd | 0.01% | New | 31,600 | $804K |
| Gsa Capital Partners LLP | 0.05% | New | 31,569 | $803K |
| Vident Advisory, LLC | 0.01% | Reduce -1.2% | 29,588 | $752K |
| Squarepoint Ops LLC | 0.00% | Add +2.3% | 26,613 | $677K |
| UBS Group AG | 0.00% | Add +31.2% | 23,885 | $607K |
| Morgan Stanley | 0.00% | Reduce -6.3% | 20,078 | $511K |
| Bank of America Corp. | 0.00% | Add +59113.8% | 17,172 | $437K |
| State Street Corp. | 0.00% | New | 11,851 | $301K |
| Legal & General Group Plc | 0.00% | New | 9,903 | $252K |
| LPL Financial LLC | 0.00% | New | 8,596 | $219K |
| Amundi | 0.00% | New | 8,595 | $219K |
| BlackRock, Inc. | 0.00% | Add +1.9% | 4,957 | $126K |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 2,231 | $57K |
| GF Fund Management Co. LTD. | 0.00% | New | 1,064 | $27K |
| EverSource Wealth Advisors, LLC | 0.00% | Add +66.9% | 918 | $23K |
| JPMorgan Chase & Co. | 0.00% | New | 845 | $20K |
| Russell Investments Group, Ltd. | 0.00% | New | 760 | $19K |
| Group One Trading LLC | 0.00% | New | 354 | $9K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 301 | $8K |
| Farther Finance Advisors, LLC | 0.00% | Reduce -55.1% | 201 | $7K |
| Osaic Holdings, Inc. | 0.00% | No change | 227 | $6K |
| Blue Trust, Inc. | 0.00% | No change | 216 | $5K |
| Royal Bank of Canada | 0.00% | New | 69 | $2K |
| Bell Investment Advisors, Inc | 0.00% | New | 20 | $509 |
| Rockefeller Capital Management L.P. | 0.00% | Reduce -73.3% | 20 | $509 |
| Cornerstone Financial Management LLC | 0.00% | New | 15 | $381 |
| Bare Financial Services, Inc | 0.00% | New | 14 | $356 |
| GAMMA Investing LLC | 0.00% | New | 8 | $203 |
| Citigroup Inc. | 0.00% | New | 1 | $25 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1 | $25 |
"% of holder's portfolio" is RGC's weight in each manager's 13F, not the share of Regencell Bioscience Holding the manager owns.